Prostate Cancer - Results from #25820

AUA 2012 - The changing "landscape" of clinical T3 prostate cancer - Session Highlights May 22, 2012

AUA 2012 - Abiraterone acetate (an androgen biosynthesis inhibitor) in patients with metastatic castration-resistant prostate cancer - Slide Presentation May 22, 2012

AUA 2012 - Differences In perioperative outcomes between African American and Caucasian patients after radical prostatectomy - Session Highlights May 22, 2012

AUA 2012 - Understanding and sequencing abiraterone acetate in patients with metastatic castration-resistant prostate cancer - Exclusive Podcast May 22, 2012

AUA 2012 - The association between male pattern baldness and second to fourth finger ratio with prostate cancer - a prospective cohort study - Poster May 22, 2012

Bone metastases from prostate, breast and multiple myeloma: Differences in lesion conspicuity at short-tau inversion recovery and diffusion-weighted MRI - Abstract May 22, 2012

Feasibility of shutter-speed DCE-MRI for improved prostate cancer detection - Abstract May 22, 2012

Randomized, double-blind, placebo-controlled phase III trial comparing docetaxel and prednisone with or without bevacizumab in men with metastatic castration-resistant prostate cancer: CALGB 90401 - Abstract May 22, 2012

The interplay of dyadic and individual planning of pelvic-floor exercise in prostate-cancer patients following radical prostatectomy - Abstract May 22, 2012

Active surveillance: The Canadian experience - Abstract May 22, 2012

Statin use as a moderator of metformin effect on risk for prostate cancer among type 2 diabetic patients - Abstract May 22, 2012

A randomized controlled trial on the effectiveness of strength training on clinical and muscle cellular outcomes in patients with prostate cancer during androgen deprivation therapy: Rationale and design - Abstract May 22, 2012

Radiation-based approaches for therapy and palliation of advanced prostate cancer - Abstract May 21, 2012

The Prostate cancer Research International - Abstract May 21, 2012

Androgen action and metabolism in prostate cancer - Abstract May 21, 2012

Celecoxib plus hormone therapy versus hormone therapy alone for hormone-sensitive prostate cancer: First results from the STAMPEDE multiarm, multistage, randomised controlled trial - Abstract May 21, 2012

Abiraterone in prostate cancer: A new angle to an old problem - Abstract May 21, 2012

Management of synchronous rectal and prostate cancer - Abstract May 21, 2012

Can choline PET tackle the challenge of imaging prostate cancer? - Abstract May 21, 2012

Primary hormonal treatment in localized and locally advanced prostate cancer: Effectiveness and survival predictive factors - Abstract May 21, 2012

Page 1292 of 1436